tirzepatide phase 3 SURMOUNT-3: shows total mean weight loss of 26.6% from study entry over 84 weeks Tirzepatide: Dual GIP/GLP-1 Receptor Agonism
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1




























